Search

Search Constraints

You searched for: Author/Creator Reynes, Jacques

Search Results

22. Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study—authors' response. (20th September 2019)

23. Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study—authors' response. (20th September 2019)

24. Efficacy and safety of emtricitabine/tenofovir alafenamide (FTC/TAF) vs. emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) as a backbone for treatment of HIV-1 infection in virologically suppressed adults: subgroup analysis by third agent of a randomized, double-blind, active-controlled phase 3 trial*. Issue 3 (4th May 2017)

25. Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa. (31st July 2015)

26. Efficacy and safety of varenicline for smoking cessation in people living with HIV in France (ANRS 144 Inter-ACTIV): a randomised controlled phase 3 clinical trial. Issue 3 (March 2018)

27. Evolution of Renal Function in African Patients Initiating Second-Line Antiretroviral Treatment: Findings from the ANRS 12169 2LADY Trial. Issue 3 (April 2017)

29. Feasibility and efficacy of early lung cancer diagnosis with chest computed tomography in HIV-infected smokers. (20th February 2016)

30. First case of mixed infection with Cryptococcus deuterogattii and Cryptococcus neoformans VNI in an Ivorian HIV-positive patient. Issue 4 (11th July 2016)